GB1426061A - Polypeptides - Google Patents

Polypeptides

Info

Publication number
GB1426061A
GB1426061A GB438773*[A GB438773A GB1426061A GB 1426061 A GB1426061 A GB 1426061A GB 438773 A GB438773 A GB 438773A GB 1426061 A GB1426061 A GB 1426061A
Authority
GB
United Kingdom
Prior art keywords
insulin
lys
ala
protease
des
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB438773*[A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB438773*[A priority Critical patent/GB1426061A/en
Priority to IE2122/73A priority patent/IE38539B1/xx
Priority to CA186,556A priority patent/CA1009974A/en
Priority to AU62979/73A priority patent/AU474971B2/en
Priority to US420573A priority patent/US3903069A/en
Priority to IL43751A priority patent/IL43751A/en
Priority to CH1759373A priority patent/CH599927A5/xx
Priority to NL7317159A priority patent/NL7317159A/xx
Priority to PL1973167350A priority patent/PL91158B1/pl
Priority to SE7317256A priority patent/SE404600B/xx
Priority to DD175618A priority patent/DD110490A5/xx
Priority to JP744631A priority patent/JPS5726760B2/ja
Priority to AT1084473A priority patent/AT348152B/de
Priority to FR7346550A priority patent/FR2212136B1/fr
Priority to LU69075A priority patent/LU69075A1/xx
Priority to ES421864A priority patent/ES421864A1/es
Priority to DE2364883A priority patent/DE2364883C2/de
Priority to HUIE605A priority patent/HU170437B/hu
Priority to US05/573,027 priority patent/US3989821A/en
Publication of GB1426061A publication Critical patent/GB1426061A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB438773*[A 1972-12-18 1973-01-29 Polypeptides Expired GB1426061A (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB438773*[A GB1426061A (en) 1972-12-28 1973-01-29 Polypeptides
IE2122/73A IE38539B1 (en) 1972-12-28 1973-11-22 Polypeptides
CA186,556A CA1009974A (en) 1972-12-28 1973-11-23 Des-lys29-ala30-insulin and production thereof
AU62979/73A AU474971B2 (en) 1972-12-28 1973-11-28 Polypeptides
US420573A US3903069A (en) 1972-12-28 1973-11-30 Polypeptides obtained by modification of porcine or bovine insulin
IL43751A IL43751A (en) 1972-12-28 1973-12-04 Des-lys29-ala30-insulins and their preparation
CH1759373A CH599927A5 (enExample) 1972-12-28 1973-12-14
NL7317159A NL7317159A (enExample) 1972-12-28 1973-12-14
PL1973167350A PL91158B1 (enExample) 1972-12-28 1973-12-15
SE7317256A SE404600B (sv) 1972-12-28 1973-12-20 Sett att framstella des-(lysŸ29-alaŸ30)-porcin-insulin och des-(lysŸ29-alaŸ30)-bovin-insulin
DD175618A DD110490A5 (enExample) 1972-12-28 1973-12-21
JP744631A JPS5726760B2 (enExample) 1972-12-28 1973-12-26
AT1084473A AT348152B (de) 1972-12-28 1973-12-27 Verfahren zur herstellung von neuen polypeptiden
FR7346550A FR2212136B1 (enExample) 1972-12-28 1973-12-27
LU69075A LU69075A1 (enExample) 1972-12-28 1973-12-27
ES421864A ES421864A1 (es) 1972-12-28 1973-12-28 Procedimiento para preparar insulinas des-lis29-ala30-por- cina y bovina.
DE2364883A DE2364883C2 (de) 1972-12-28 1973-12-28 Des-Lys↑2↑↑9↑-Ala↑3↑↑0↑-Schweine- und -Rinderinsulin, Verfahren zu deren Herstellung und diese Insuline enthaltende injizierbare Präparate
HUIE605A HU170437B (enExample) 1972-12-28 1973-12-28
US05/573,027 US3989821A (en) 1972-12-18 1975-04-30 Polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5974272 1972-12-28
GB438773*[A GB1426061A (en) 1972-12-28 1973-01-29 Polypeptides

Publications (1)

Publication Number Publication Date
GB1426061A true GB1426061A (en) 1976-02-25

Family

ID=26239087

Family Applications (1)

Application Number Title Priority Date Filing Date
GB438773*[A Expired GB1426061A (en) 1972-12-18 1973-01-29 Polypeptides

Country Status (18)

Country Link
US (1) US3903069A (enExample)
JP (1) JPS5726760B2 (enExample)
AT (1) AT348152B (enExample)
AU (1) AU474971B2 (enExample)
CA (1) CA1009974A (enExample)
CH (1) CH599927A5 (enExample)
DD (1) DD110490A5 (enExample)
DE (1) DE2364883C2 (enExample)
ES (1) ES421864A1 (enExample)
FR (1) FR2212136B1 (enExample)
GB (1) GB1426061A (enExample)
HU (1) HU170437B (enExample)
IE (1) IE38539B1 (enExample)
IL (1) IL43751A (enExample)
LU (1) LU69075A1 (enExample)
NL (1) NL7317159A (enExample)
PL (1) PL91158B1 (enExample)
SE (1) SE404600B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983002772A1 (en) * 1982-02-08 1983-08-18 Robin Ewart Offord An improved method for preparing human insulin from non-human insulin

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK146482C (da) * 1979-04-13 1986-10-06 Shionogi & Co Fremgangsmaade til fremstilling af et b30-threonin-insulin
JPS55138391A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd New synthetic method of peptide derivative
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
US6673347B1 (en) 1986-04-30 2004-01-06 Gryphon Therapeutics Polypeptide and protein derivatives and process for their preparation
GB8610551D0 (en) * 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
PH23446A (en) * 1986-10-20 1989-08-07 Novo Industri As Peptide preparations
WO1990007522A1 (en) * 1988-12-23 1990-07-12 Novo Nordisk A/S Human insulin analogues
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH471220A (de) * 1964-05-09 1969-04-15 Roehm & Haas Gmbh Verfahren zur Herstellung einer L-Leucinamid, Hypertensin und Oxytocin spaltenden Aminopeptidase

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983002772A1 (en) * 1982-02-08 1983-08-18 Robin Ewart Offord An improved method for preparing human insulin from non-human insulin
EP0087238A1 (en) * 1982-02-08 1983-08-31 Biogen N.V. Am improved method for preparing human insulin from non-human insulin

Also Published As

Publication number Publication date
SE404600B (sv) 1978-10-16
AU6297973A (en) 1975-05-29
ES421864A1 (es) 1976-08-01
DE2364883A1 (de) 1974-07-04
JPS4994698A (enExample) 1974-09-09
FR2212136B1 (enExample) 1978-01-06
AU474971B2 (en) 1976-08-05
LU69075A1 (enExample) 1974-03-07
DE2364883C2 (de) 1984-07-19
ATA1084473A (de) 1978-06-15
IL43751A0 (en) 1974-03-14
CA1009974A (en) 1977-05-10
FR2212136A1 (enExample) 1974-07-26
IE38539B1 (en) 1978-04-12
PL91158B1 (enExample) 1977-02-28
US3903069A (en) 1975-09-02
CH599927A5 (enExample) 1978-06-15
IE38539L (en) 1974-06-28
DD110490A5 (enExample) 1974-12-20
HU170437B (enExample) 1977-06-28
JPS5726760B2 (enExample) 1982-06-07
AT348152B (de) 1979-02-12
NL7317159A (enExample) 1974-07-02
IL43751A (en) 1977-01-31

Similar Documents

Publication Publication Date Title
EP0307592A3 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
NL194828B (nl) Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
RU93046317A (ru) Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции
RU94046251A (ru) Глюкагоноподобный пептид и производные инсулино-тропина, способ получений, фармацевтические композиции, способы лечения диабета
CA1267496C (en) PURIFICATION AND ACTIVATION OF INSOLUBLE INCLUSION BODY PROTEINS
FI943591A7 (fi) Synteettinen hemofilus-influenssa yhdistelmärokote
IS2070B (is) Stöðugar interferónlyfjablöndur á vökvaformi
GR1000083B (el) Μυκητοβακτηριακα προιοντα εξ ανασυνθεσεως και πεπτιδια.
CA2094027A1 (en) Osteogenic peptides
GB1426061A (en) Polypeptides
DK0430200T3 (da) Polypeptidholdigt lægemiddel til subkutan eller intramuskulær applikation
IL79972A (en) Protein recovery from inclusion bodies produced in transformant microorganisms
ATE144535T1 (de) Plättchen blockierende peptide
GB1261230A (en) Acyl-substituted insulins
KR900003371A (ko) 재조합 천연 킬러 세포 활성화제
AU580350B2 (en) Process for synthesising peptides
AU3629389A (en) Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same
EP0239311A3 (en) Mutual separation of proteins
HUT44609A (en) Process for preparing new polypeptides
CA972288A (en) Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity
CA2171953A1 (en) Modified truncated complement system regulators
FI891020A0 (fi) Menetelmä proteaasi-inhibiittoriaktiivisuutta omaavien egliinimutanttien valmistamiseksi
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
AU7378087A (en) Interleukin-2 induced antineoplastic peptide
US3651231A (en) Process for preparing lactogenic factor

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee